Published online Sep 6, 2022. doi: 10.12998/wjcc.v10.i25.8808
Peer-review started: April 2, 2022
First decision: May 30, 2022
Revised: June 1, 2022
Accepted: July 25, 2022
Article in press: July 25, 2022
Published online: September 6, 2022
Processing time: 145 Days and 17.4 Hours
Core Tip: The most common otorhinolaryngological manifestations of coronavirus disease 2019 (COVID-19) are olfactory dysfunctions rather than other symptoms (sore throat, nasal obstruction, deafness, dysphonia, tinnitus, etc.). They might be present alone or associated with other common features of the disease (fever, cough, myalgia, headache and dyspnea). Adverse effects of the COVID-19 vaccines include local injection pain, fever, myalgia, headache, and others. Otorhinolaryngological side effects like Bell’s palsy, anosmia and deafness due to COVID-19 vaccines are reported in the literature as individual cases or small case series. We review the currently available evidence regarding the otorhinolaryngological features of COVID-19 or after vaccination.
